ecklonia
cava
edibl
seawe
found
asian
countri
japan
korea
major
compon
includ
fucoidan
phlorotannin
phlorotannin
isol
e
cava
wellknown
antioxid
effect
strong
antivir
activ
porcin
epidem
diarrhea
viru
pedv
high
mortal
rate
piglet
studi
bioactiv
compon
determin
base
two
differ
approach
bioguid
isol
use
antivir
activ
viral
strain
repres
influenza
viru
origin
swine
ii
highresolut
mass
spectrometrybas
derepl
includ
rel
mass
defect
rmd
hplcqtofm
fragment
analysi
fraction
show
strongest
antivir
activ
contain
thirteen
phlorotannin
predict
derepl
ten
compound
directli
isol
e
cava
extract
identifi
moreov
derepl
method
allow
discoveri
two
new
phlorotannin
structur
two
isol
compound
elucid
use
nmr
techniqu
hplcqtofm
fragment
analysi
addit
molecular
model
appli
determin
absolut
configur
two
new
compound
antivir
activ
seven
major
phlorotannin
activ
fraction
evalu
two
influenza
viral
strain
six
compound
show
moder
strong
effect
virus
phlorofucofuroeckol
show
ec
valu
potenti
activ
antivir
compon
e
cava
ecklonia
cava
edibl
seawe
belong
laminariacea
famili
found
asian
countri
japan
korea
e
cava
nutrientdens
food
contain
mani
type
organ
compound
includ
fucoidan
phlorotannin
variou
biolog
activ
antioxid
antiallerg
antiplasmin
inhibitori
anticanc
meoh
extract
e
cava
show
antivir
activ
cytopath
effect
cpe
assay
compar
ribavirin
posit
control
figur
divid
five
fraction
diaion
column
gradient
meoh
h
vv
final
aceton
antivir
activ
five
fraction
indic
subfract
elut
meoh
strongest
antivir
activ
cell
three
differ
concentr
figur
thu
fraction
chosen
bioguid
isol
derepl
use
hplcqtofm
identifi
predict
bioactiv
compound
figur
potenti
compon
virus
test
viral
protein
synthesi
viru
figur
madindarbi
canin
kidney
mdck
cell
infect
influenza
virus
h
treat
test
compound
ribavirin
posit
control
percentag
cell
surviv
evalu
three
day
incub
use
cpe
inhibit
assay
data
express
mean
sd
n
p
p
p
compar
viru
control
group
derepl
secondari
metabolit
e
cava
accomplish
hplcqtofm
analysi
activ
fraction
hplcqtofm
data
use
databas
construct
base
chromatograph
retent
time
fullscan
highresolut
mass
spectra
msm
spectra
neg
electrospray
ioniz
esi
mode
secondari
metabolit
fraction
identifi
comparison
compound
previous
report
ecklonia
genu
speci
list
tabl
support
inform
onlin
scifind
inhous
databas
base
exact
mass
rmd
use
masshunt
quantit
softwar
identifi
compound
shown
base
peak
ms
msm
chromatogram
figur
e
ms
ms
data
peak
detect
spectra
list
tabl
rmd
valu
peak
use
determin
chemic
skeleton
structur
compon
identifi
comparison
msm
fragment
peak
tabl
inhous
librari
shown
figur
compon
fraction
could
classifi
phlorotannin
fatti
acid
other
compound
differ
rang
rmd
valu
rmd
valu
detect
phlorotannin
smaller
compound
approxim
ppm
due
natur
structur
phlorotannin
figur
support
inform
posit
absolut
mass
defect
usual
observ
compound
contain
larg
number
hydrogen
atom
mass
defect
mda
wherea
lower
valu
observ
compound
larg
number
oxygen
mass
defect
mda
nitrogen
atom
mass
defect
mda
fatti
acid
contain
mani
hydrogen
larg
rmd
valu
suggest
compound
tabl
figur
oxygen
major
elementari
build
block
phlorotannin
reduc
rmd
valu
group
particularli
studi
less
ppm
demonstr
compound
tabl
featur
help
studi
genu
ecklonia
contain
phlorotannin
major
compon
first
step
screen
hplcqtofm
calcul
rmd
valu
detect
peak
facilit
identif
phlorotannin
allow
research
derepl
report
compound
especi
genu
rmd
valu
list
unidentifi
peak
tabl
also
use
estim
type
structur
associ
detect
peak
furthermor
polyphenol
lower
hydrogen
content
higher
oxygen
content
compar
type
compound
result
lower
rmd
valu
consist
seen
phlorotannin
thu
studi
classif
base
rmd
valu
suitabl
type
polyphenol
compound
broadli
appli
screen
natur
resourc
particular
speci
brown
alga
phlorotannintyp
compound
easili
classifi
main
compon
speci
phlorotannin
compos
phloroglucinol
unit
wellknown
major
compon
genu
ecklonia
overal
phlorotannin
divid
four
class
base
type
linkag
connect
phloroglucinol
unit
includ
etherbound
phlorotannin
fuhalol
phlorethol
phenylbound
phlorotannin
fucol
ether
phenylbound
phlorotannin
fucophlorethol
dibenzodioxinbound
fucophlorethol
eckol
carmalol
monom
class
link
variou
posit
thu
possibl
mani
structur
isom
molecular
weight
fragment
pattern
observ
peak
therefor
key
structur
identif
indic
differ
loss
phloroglucinol
monom
hydroxyl
group
previou
studi
necessari
isol
compound
use
combin
ms
nmr
spectroscopi
elucid
exact
structur
phlorotannin
recent
attempt
made
classifi
type
phlorotannin
sargassum
fursiform
without
isol
use
ultrahighperform
liquid
chromatographi
tripl
quadrupol
tandem
mass
spectrometri
uhplcqqqm
first
time
studi
propos
effici
method
derepl
variou
phlorotannin
deriv
major
constitu
seawe
base
preliminari
hplcqtofm
accompani
rmd
analysi
moreov
hypothesi
derepl
valid
isol
structur
elucid
phlorotannin
use
nmr
hplcqtofm
msm
data
peak
detect
fraction
anticip
compon
list
tabl
shown
figur
tabl
fortyon
peak
observ
hplcqtofm
spectroscop
data
activ
fraction
compound
tabl
identifi
phlorotannin
base
comparison
rmd
valu
molecular
weight
msm
fragment
literatur
data
accord
msm
data
thirteen
compound
identifi
eckoltyp
phlorotannin
contain
least
one
fragment
structur
mostli
found
ecklonia
genu
seawe
fragment
peak
observ
msm
pattern
compound
reveal
loss
phloroglucinol
amu
pentahydroxyl
dibenzodioxin
accord
derepl
result
ten
known
phlorotannin
directli
isol
fraction
valid
accuraci
identif
ten
compound
measur
hplcqtofm
neg
ion
mode
collis
energi
ev
confirm
retent
time
figur
support
inform
fragment
pattern
isol
phlorotannin
present
figur
support
inform
result
reveal
hplcqtofm
power
tool
identifi
structur
phlorotannin
especi
case
isom
provid
suffici
data
elucid
chemic
structur
exampl
msm
fragment
pattern
compound
mz
present
detail
identifi
tabl
compound
establish
compound
due
low
rmd
valu
ppm
characterist
fragment
observ
mz
isol
exact
structur
confirm
nmr
spectroscopi
conjunct
msm
fragment
figur
support
inform
product
ion
shown
figur
studi
seven
major
phlorotannin
isol
fraction
use
bioactivityguid
isol
test
antivir
activ
two
influenza
viral
strain
viru
strain
figur
result
indic
six
compound
moder
strong
antivir
activ
viral
strain
concentr
compound
display
potent
antivir
effect
test
viral
protein
synthesi
viru
compar
ribavirin
posit
control
result
shown
figur
tabl
support
inform
suggest
compound
activ
compound
ec
thu
dosedepend
inhibitori
effect
compound
viral
protein
synthesi
evalu
four
differ
concentr
madindarbi
canin
kidney
mdck
cell
shown
figur
clear
higher
concentr
effect
inhibit
protein
express
viralinfect
cell
compound
decreas
express
neuraminidas
hemagglutinin
strongest
inhibit
capac
observ
fluoresc
imag
shown
figur
also
explain
inhibitori
effect
compound
neuraminidas
protein
express
infect
mdck
cell
result
suggest
compound
show
strong
antivir
activ
inhibit
express
surfac
glycoprotein
hemagglutinin
neuraminidas
concentrationdepend
inhibitori
effect
compound
viral
protein
synthesi
mdck
cell
infect
influenza
viru
h
treat
test
compound
ribavirin
posit
control
h
western
blot
perform
intern
control
specif
antibodi
neuraminidas
hemagglutinin
data
present
mean
sd
n
p
p
p
p
p
p
compar
neuraminidas
hemagglutinin
viru
control
group
respect
c
compound
decreas
neuraminidas
protein
express
viralinfect
cell
cytoplasm
variou
concentr
fluoresc
imag
determin
immunocytochemistri
use
fluoresc
microscop
result
derepl
fraction
suggest
quick
method
identifi
phlorotannin
henc
attempt
isol
new
phlorotannin
fraction
e
cava
base
msm
fragment
pattern
rmd
valu
hplcqtofm
data
fraction
e
cava
export
rmd
valu
detect
peak
calcul
compound
mz
tabl
mz
tabl
show
rmd
valu
ppm
fragment
present
inhous
databas
onlin
databas
ecklonia
genu
suggest
compound
might
new
phlorotannin
figur
thu
two
compound
isol
confirm
chemic
structur
nmr
spectroscopi
along
molecular
model
msm
fragment
analysi
compound
obtain
brown
powder
molecular
formula
determin
c
h
c
nmr
signal
correspond
thirteen
unsubstitut
c
ppm
twentythre
oxygen
aromat
carbon
c
ppm
assign
base
hsqc
hmbc
correl
figur
respect
support
inform
data
suggest
compound
contain
six
phloroglucinol
unit
coupl
constant
proton
signal
hmbc
data
confirm
pattern
substitu
figur
support
inform
signal
h
metacoupl
doublet
h
similar
eckol
thu
assign
ring
b
respect
similarli
structur
presum
includ
c
e
f
ring
fucodiphloroethol
g
comparison
report
nmr
data
two
carbon
signal
c
ppm
also
indic
structur
contain
one
bond
similar
fucodiphloroethol
g
howev
asymmetr
structur
c
ring
reveal
fucodiphloroethol
eckol
moieti
link
c
ring
roesi
correl
ring
hydroxyl
c
ring
figur
support
inform
suggest
phenyl
linkag
connect
c
ring
longrang
coupl
proton
ring
c
well
ring
b
e
explain
posit
deriv
threedimension
structur
optim
use
molecular
model
figur
support
inform
comprehens
explan
structur
obtain
msm
data
shown
figur
support
inform
fragment
ion
correspond
c
h
mz
calcd
mmu
main
fragment
detect
fragment
explain
loss
phloroglucinol
unit
amu
pentahydroxyl
dibenzodioxin
amu
particular
fragment
mz
amu
loss
one
phloroglucinol
two
water
molecul
amu
two
phloroglucinol
unit
one
oxygen
atom
amu
three
phloroglucinol
one
water
amu
pentahydroxyl
dibenzodioxin
two
proton
amu
therefor
chemic
structur
determin
dibenzodioxinfucodiphloroethol
dfd
compound
obtain
brown
powder
molecular
formula
establish
c
h
br
two
set
metacoupl
singlet
h
br
br
br
br
c
nmr
spectrum
figur
support
inform
show
signal
chemic
shift
rang
aromat
carbon
thirteen
proton
carbon
signal
c
ppm
along
thirtysix
oxygen
aromat
carbon
signal
locat
rang
ppm
suggest
presenc
nine
aromat
ring
structur
carbon
signal
c
nmr
spectrum
assign
base
hsqc
hmbc
correl
tabl
figur
support
inform
compar
report
phlorotannin
chemic
shift
atom
ring
b
c
similar
belong
similarli
chemic
shift
atom
ring
e
f
g
assign
base
structur
fucodiphloroethol
g
bond
ring
f
g
confirm
chemic
shift
c
ppm
addit
remain
two
aromat
ring
suggest
ring
h
base
msm
fragment
analysi
fragment
amu
suggest
vicin
trihydroxyl
structur
compound
figur
support
inform
characterist
bifuhalol
unit
contain
extra
hydroxyl
group
termin
phlorotannin
unit
connect
fragment
determin
roesi
spectrum
figur
support
inform
correl
signal
correspond
ring
b
ring
c
ring
c
ring
ring
confirm
connect
ring
shown
figur
support
inform
moieti
connect
posit
ring
e
base
roesi
correl
ring
e
ring
similar
compound
longrang
correl
proton
ring
well
ring
b
g
support
optim
threedimension
structur
obtain
use
molecular
model
figur
support
inform
fragment
inform
hrmsm
data
describ
figur
support
inform
also
support
chemic
structur
compound
fragment
observ
figur
support
inform
mz
amu
explain
loss
one
phloroglucinol
unit
amu
two
phloroglucinol
unit
addit
one
water
amu
one
eckol
one
bifuhalol
addit
one
acet
acid
one
water
amu
bifuhalol
fragment
amu
final
exact
structur
elucid
dibenzodioxinfucodiphloroeckol
dfe
paper
develop
derepl
strategi
use
rmd
valu
base
gener
derepl
strategi
determin
similar
msm
fragment
pattern
standard
compound
unknown
compound
howev
unlik
gener
derepl
method
rmd
use
group
compound
type
show
overal
phytochem
trend
type
secondari
metabolit
extract
e
cava
phlorotannin
dieckol
phloroglucinol
eckol
phlorofucofuroeckol
etc
report
antivir
activ
pedv
viral
hemorrhag
septicemia
viru
vhsv
human
papilloma
viru
hpv
murin
noroviru
mnv
howev
studi
method
produc
bioactiv
fraction
develop
fraction
could
use
obtain
antivir
materi
total
extract
addit
seven
lead
compound
identifi
purifi
bioactiv
fraction
therefor
fraction
e
cava
extract
isol
phlorotannin
shown
potenti
industri
applic
prevent
treatment
influenza
virus
present
studi
discuss
use
msm
fragment
analysi
coupl
rmd
filter
derepl
method
identifi
phlorotannin
bioactiv
substanc
ecknolia
genu
especi
ecknolia
cava
best
knowledg
first
attempt
appli
postevalu
accuraci
rmd
valu
conjunct
msm
analysi
identif
phlorotannin
result
derepl
studi
provid
quick
initi
screen
phlorotannin
motif
compound
show
rmd
valu
less
ppm
typic
fragment
loss
phloroglucinol
unit
addit
differ
rang
rmd
valu
suggest
presenc
differ
type
structur
present
compound
msm
use
derepl
also
provid
strong
evid
confirm
structur
phlorotannin
fragment
base
derepl
method
two
new
compound
identifi
elucid
spectroscopi
addit
studi
conduct
identifi
antivir
lead
compound
e
cava
use
bioguid
isol
result
suggest
phlorofucofuroeckol
e
cava
play
key
role
antivir
activ
seawe
viru
strong
inhibitori
effect
compound
neuraminidas
hemagglutinin
suggest
could
potenti
agent
develop
antivir
drug
optic
rotat
determin
jasco
polarimet
jasco
intern
co
ltd
tokyo
japan
ir
spectra
record
nicolet
ftir
spectromet
thermo
electron
corp
waltham
usa
nmr
data
measur
dmsod
record
mhz
spectromet
colleg
pharmaci
seoul
nation
univers
korea
esim
data
record
agil
seri
lcmsd
trap
agil
technolog
waldbronn
germani
activ
fraction
analys
tlc
thinlay
chromatographi
silica
gel
plate
merck
darmstadt
germani
spray
vanillin
reagent
contain
g
vanillin
ml
sulfur
acid
ml
ethanol
develop
plate
compound
tlc
plate
detect
nm
column
chromatographi
separ
carri
use
variou
resin
includ
diaion
mitsubishi
chemic
co
tokyo
japan
sephadex
sigmaaldrich
corp
st
loui
missouri
usa
silica
gel
merck
particl
size
c
rp
silica
gel
merck
particl
size
prepar
hplc
separ
perform
use
gilson
system
optima
pak
c
column
mm
mm
particl
size
rs
tech
seoul
korea
uv
detector
wavelength
nm
solvent
use
extract
isol
analyt
grade
stabl
configur
compound
figur
support
inform
calcul
conflex
conflex
corp
tokyo
japan
use
molecular
mechan
forcefield
calcul
search
limit
kcalmol
dri
powder
e
cava
g
extract
meoh
l
room
temperatur
ultrason
two
day
filtrat
combin
meoh
solut
concentr
reduc
pressur
yield
dri
extract
g
crude
extract
suspend
distil
water
l
fraction
use
diaion
four
litr
water
use
elut
salt
two
litr
meoh
meoh
meoh
aceton
use
elut
system
obtain
five
fraction
fraction
elut
meoh
chromatograph
reversedphas
silica
gel
column
gradient
meohh
yield
five
subfract
scheme
support
inform
subfract
subject
sephadex
column
elut
meoh
afford
four
fraction
fraction
hplcqtofm
perform
agil
seri
instrument
agil
technolog
usa
dual
esi
interfac
colleg
pharmaci
seoul
nation
univers
korea
ymctriart
c
column
mm
mm
id
use
separ
elut
gradient
consist
h
mecn
b
buffer
formic
acid
increas
b
b
fraction
b
fraction
min
mlmin
held
min
mlmin
return
b
min
maintain
min
mlmin
nitrogen
use
dri
ga
collis
ga
esi
sourc
electrospray
ion
sourc
paramet
follow
dri
ga
flow
rate
lmin
heat
capillari
temperatur
c
sheath
ga
temperatur
c
flow
lmin
nebul
pressur
psi
vcap
fragmentor
skimmer
octopol
rf
peak
voltag
set
v
respect
detect
carri
posit
neg
electrospray
ioniz
mode
spectra
record
ms
scan
rang
mz
msm
analys
carri
target
fragment
collis
energi
set
ev
fraction
ev
singl
compound
masshunt
softwar
version
agil
technolog
use
control
lcmsm
system
version
use
data
acquisit
analysi
process
includ
predict
chemic
formula
exact
mass
calcul
cell
viabil
evalu
mtt
bromid
assay
briefli
mdck
cell
seed
plate
cell
per
well
incub
h
cultur
replac
dmemfre
serum
treat
test
compound
h
avoid
solvent
toxic
final
concentr
dimethyl
sulfoxid
dmso
maintain
vv
subsequ
mgml
mtt
solut
ad
well
plate
incub
h
c
remov
medium
formazan
crystal
dissolv
dmso
absorb
measur
nm
use
micropl
reader
versamaxtm
randor
pa
usa
experi
perform
triplic
regress
analysi
appli
calcul
cytotox
concentr
cc
mdck
cell
seed
onto
plate
incub
h
wash
twice
phosphatebuff
salin
pb
cell
infect
influenza
virus
use
dmem
contain
trypsin
bsa
h
cell
wash
pb
new
media
contain
fraction
test
compound
differ
concentr
ad
incub
three
day
c
co
atmospher
medium
replac
dmem
mgml
mtt
ad
well
plate
incub
addit
h
next
step
follow
typic
cytotox
assay
procedur
effect
concentr
ec
calcul
regress
analysi
mdck
cell
grown
plate
infect
viru
h
cell
wash
pb
media
replac
new
media
variou
concentr
test
compound
h
incub
cell
wash
cold
pb
lyse
lysi
buffer
mm
trishcl
ph
mm
nacl
mm
edta
mm
naf
supernat
collect
protein
concentr
determin
use
protein
assay
kit
bio
rad
laboratori
inc
usa
aliquot
lysat
boil
min
load
onto
sdspolyacrylamid
gel
gel
electrophores
electrotransf
polyvinyliden
fluorid
membran
pvdf
immobilonp
usa
block
skim
milk
solut
membran
incub
overnight
c
primari
antibodi
name
neuraminidas
gene
tex
san
antonio
tx
usa
hemagglutinin
sigma
st
loui
mo
usa
mous
monoclon
actin
abcam
cambridg
uk
wash
time
pb
membran
incub
secondari
antibodi
h
detect
chemiluminesc
western
blot
detect
kit
thermo
fisher
scientif
rockford
il
usa
use
imag
quant
tm
imag
system
mdck
cell
maintain
steril
glass
coverslip
infect
viru
h
cell
transfer
new
media
contain
test
compound
variou
concentr
cultur
incub
c
co
atmospher
h
fixat
permeabil
cell
block
bovin
serum
albumin
bsa
solut
sigma
st
loui
mo
usa
h
incub
overnight
monoclon
neuraminidas
antibodi
gene
tex
dilut
pb
cell
incub
secondari
antibodi
fitc
fluoresc
isothiocyan
conjug
goat
antirb
igg
abcam
cambridg
uk
h
nuclei
stain
nm
dapi
thermo
fisher
scientif
usa
solut
min
room
temperatur
slide
mount
mount
medium
fluoresc
vectashield
vector
lab
inc
usa
immunofluoresc
imag
acquir
fluoresc
microscopi
olympu
fluoresc
microscop
olympu
corpor
tokyo
japan
result
present
mean
sd
three
independ
experi
signific
differ
group
calcul
oneway
analysi
varianc
anova
use
tukey
duncan
post
hoc
test
conduct
spss
statist
softwar
spss
inc
chicago
il
usa
statist
signific
accept
p
p
p
imagej
softwar
appli
western
blot
analysi
supplementari
materi
follow
avail
onlin
http
figur
hresim
spectrum
compound
figur
ir
spectrum
compound
figur
figur
relationship
ion
mass
mz
valu
neg
ion
mode
rmd
valu
compound
detect
hplcqtofm
fraction
figur
hplcqtofm
measur
twelv
isol
compound
neg
ion
mode
collis
energi
ev
figur
msm
spectra
fragment
ion
analysi
isol
compound
hplcqtofm
spectroscop
data
singl
compound
measur
neg
mode
collis
energi
ev
figur
effect
compound
viral
protein
synthesi
concentr
origin
uncrop
blot
figur
inhibitori
effect
compound
viral
protein
synthesi
concentrationdepend
manner
origin
uncrop
blot
figur
key
hmbc
correl
compound
b
key
roesi
correl
structur
compound
figur
physicochem
properti
isol
known
compound
e
cava
tabl
list
speci
ecklonia
genu
websit
world
regist
marin
speci
http
wwwmarinespeciesorg
tabl
inhibitori
effect
compound
viru
cytopath
effect
cytotox
assay
tabl
h
c
nmr
spectroscop
data
compound
dmsod
ppm
scheme
extract
fraction
procedur
e
cava
author
declar
conflict
interest
